This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Omic Smap Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Sehan Lee: Innovator in Cancer Treatment
Introduction
Sehan Lee is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cancer. His innovative work has the potential to impact cancer therapies positively.
Latest Patents
Sehan Lee holds a patent for a Quinazoline-2,4-diamine derivative and pharmaceutical composition for preventing or treating cancer. This invention includes a compound, a stereoisomer thereof, a hydrate thereof, or a pharmaceutically acceptable salt thereof. The compound exhibits a high inhibitory ability on euchromatic histone-lysine N-methyltransferase 2 (EHMT2), making it a promising candidate for cancer treatment.
Career Highlights
Sehan Lee is associated with Omic Smap Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His dedication to research and development has led to advancements in cancer treatment methodologies.
Collaborations
Sehan collaborates with talented individuals such as Jung Jin Hwang and Sang Eun Park. Their combined expertise enhances the research efforts at Omic Smap Inc. and contributes to the development of effective cancer therapies.
Conclusion
Sehan Lee's work exemplifies the spirit of innovation in the pharmaceutical field. His contributions, particularly in cancer treatment, highlight the importance of research and collaboration in advancing medical science.